ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $496K of Zentalis Pharmaceuticals, Inc.
Sold$495,827
$49.58Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Wed, Jul 7 open, $46.32
- +12.4%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Aug 18 close.
Traded Fri, Jul 2. Filed Tue, Jul 6, 4:00 PM ET, after the close. Returns use the Jul 7 open and the Aug 18 close. Not investment advice.